Novel SA53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically-Targeted Cancer Treatment (CLEVELAND, OH) – Lamassu Biotech, a clinical-stage pharmaceutical company, today announced a significant clinical milestone...
Category: news
Brothers Recognized for Their Pioneering Work in Cancer Treatment (CLEVELAND, OH) – Drs. Rabi and Gabi Hanna, two brothers who immigrated to the United States, now making pioneering strides in...
(DURHAM, NC) – Lamassu Pets, the veterinary division of Lamassu Biotech, has announced the appointment of veteran animal health industry executive Michael Kelly to its Advisory Board. Widely respected in the animal health pharmaceutical sector, Kelly brings more...